Report: Clinical Decision Support Market to Reach $4.97B by 2021 | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Report: Clinical Decision Support Market to Reach $4.97B by 2021

July 19, 2017
by Rajiv Leventhal
| Reprints

A changing healthcare landscape that includes a shift to value-based reimbursement will transform the clinical decision support systems (CDSS) market in the U.S., according to a report from Frost & Sullivan.

The report noted that the advent of meaningful use and changing documentation requirements to achieve reimbursement are creating a complex and connected CDS infrastructure that includes digital workflow, electronic health records (EHRs) and point-of-care solutions.

EHRs are expected to be the hub for CDSS as growing volumes of patient data from a variety of sources will encourage workflow improvements to enable patient surveillance at the point-of-care.  These systems will further evolve to include the pool of patient data needed to develop predictive analytics and enhance the performance of population health systems, the report stated.

As such, researchers have predicted that the overall U.S. CDSS market is expected to be worth $4.97 billion in 2021. “The introduction of value-based reimbursements and quality performance measures will increase the value of evidence-based data to document a clinical rationale and support medical decision making," Digital Health Principal Analyst Victor Camlek said in a statement. "Essentially, the CDSS market will comprise a wide array of companies, ranging from established clinical content providers to vendors of medical devices, analytical services, and workflow tools. This emerging ecosystem will encourage alliances and merger/acquisition activity, and underscore the necessity for a dedicated CDSS infrastructure vital to improving patient outcomes,” he said.

Indeed, key growth opportunities for the market will involve:

  • Enhancing EHRs by including CDS data and working toward fully interoperable EHRs;
  • Extending CDSS to population health systems by feeding in actionable data;
  • Refining and advancing clinical surveillance technology; and
  • Including access to patients who will benefit from the ability to retrieve accurate and relevant data pertaining to their medical condition that will encourage improved adherence and outcomes.

"The challenge will be to make CDSS a resource that is appropriate for all stakeholders that is compliant with privacy and security guidelines, and flexible enough to function in a constantly evolving healthcare regulatory environment," added Camlek.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More



Healthcare Execs Anticipate High Cost Returns from Predictive Analytics Use

Healthcare executives are dedicating budget to predictive analytics, and are forecasting significant cost savings in return, according to new research from the Illinois-based Society of Actuaries.

Adam Boehler Tapped by Azar to Serve as Senior Value-Based Care Advisor

Adam Boehler, currently director of CMMI, has also been named the senior advisor for value-based transformation and innovation, HHS Secretary Alex Azar announced.

Vivli Launches Clinical Research Data-Sharing Platform

On July 19 a new global data-sharing and analytics platform called Vivli was unveiled. The nonprofit group’s mission is to promote, coordinate and facilitate scientific sharing and reuse of clinical research data.

Survey: More Effective IT Needed to Improve Patient Safety

In a Health Catalyst survey, physicians, nurses and healthcare executives said ineffective information technology, and the lack of real-time warnings for possible harm events, are key obstacles to achieving their organizations' patient safety goals.

Physicians Still Reluctant to Embrace Virtual Tech, Survey Finds

While consumers and physicians agree that virtual healthcare holds great promise for transforming care delivery, physicians still remain reluctant to embrace the technologies, according to a new Deloitte Center for Health Solutions survey.

Geisinger, AstraZeneca Partner on Asthma App Suite

Geisinger has partnered with pharmaceutical company AstraZeneca to create a suite of products that integrate into the electronic health record and engage asthma patients and their providers in co-managing the disease.